Search

Your search keyword '"Kobie, James J."' showing total 68 results

Search Constraints

Start Over You searched for: Author "Kobie, James J." Remove constraint Author: "Kobie, James J." Database Unpaywall Remove constraint Database: Unpaywall
68 results on '"Kobie, James J."'

Search Results

2. SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responses

3. Correction for Piepenbrink et al., “Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies”

4. Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies

5. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission

9. Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens

11. Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody

12. Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody

13. CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques

14. Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses

16. Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses

17. Visualization of SARS-CoV-2 infection dynamic

21. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

22. Polyfunctional Tier 2–Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor

24. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

25. Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

26. Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans

34. A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

38. A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association

39. Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques

41. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users

47. 9G4+ Antibodies Isolated from HIV-Infected Patients Neutralize HIV-1 and Have Distinct Autoreactivity Profiles

50. 9G4 Autoreactivity Is Increased in HIV-Infected Patients and Correlates with HIV Broadly Neutralizing Serum Activity

Catalog

Books, media, physical & digital resources